-
the Open Discovery Innovation Network (ODIN), which has been extended by the Novo Nordisk Foundation for 5 years. ODIN has pioneered a new and patent-free collaboration model, where industry and academia
-
grant from the Novo Nordisk Foundation. Start date is 1 October 2024 or as soon as possible thereafter. The project BoostR is an innovative and multidisciplinary research program to identify and
-
starting as soon as possible. Position Description: The position is funded by an Interdisciplinary Synergy Grant from the Novo Nordisk Foundation for the project BioNWire. The project aims to self-assemble a
-
. The positions will be embedded in RNA-META, Centre for RNA Therapeutics towards Metabolic Diseases ( https://inano.au.dk/about/research-centers-and-projects/rna-meta/research), founded by Novo Nordisk Foundation
-
working with newborn infants, neonatal mice and preterm lambs. Project description This PhD position will be a part of a project funded by the Novo Nordisk Foundation within Basic Bioscience and Biomedicine
-
Skip to main content. Profile Sign Out View More Jobs Professor in Industrial Biotechnology - DTU Biosustain Kgs. Lyngby, Denmark Be the First to Apply Job Description The Novo Nordisk Foundation
-
Skip to main content. Profile Sign Out View More Jobs Fermentation Specialist - DTU Biosustain Kgs. Lyngby, Denmark Be the First to Apply Job Description The department Novo Nordisk Foundation
-
have it right here. As an internationally reputed elite university, DTU is at the forefront of innovation related to “the sustainable transition.” At the Novo Nordisk Foundation Center
-
Postdoc in statistics to develop Bayesian privacy metrics for synthetic health data (2024-224-05725)
scientist, students, and a student helper. The project is a part of the ambitious Novo Nordisk Foundation Data Science Collaborative Programme,“Synthetic health data: ethical development and deployment via
-
A postdoc is available at the Department of Plant and Environmental Sciences. The postdoc will be financed by a grant from the Novo Nordisk foundation to Associate Prof. Hussam Hassan Nour-Eldin